GO:0033211 adiponectin-activated signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033211 describes the signaling cascade triggered when adiponectin binds its receptor, leading to downstream cellular regulation such as transcription.
• Adiponectin signaling commonly engages AMPK, ERK1/2, p38, and PPARgamma to control metabolism, proliferation, and differentiation.
• The pathway suppresses hypertrophic and inflammatory signals in the heart and vasculature, and its loss promotes arterial calcification.
• In cancer, adiponectin signaling can induce breast cancer cell death via fatty acid metabolic reprogramming and attenuate malignant mesothelioma growth.
• Key experimental models include adiponectin-deficient mice, myoblast and satellite cell cultures, and mesangial cells.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of adiponectin pathway components.
Description
The adiponectin-activated signaling pathway (GO:0033211) is a biological process defined as the series of molecular signals initiated by adiponectin binding to its receptor on the cell surface, ending with regulation of a downstream cellular process such as transcription. Adiponectin is an adipocyte-secreted cytokine that exerts pleiotropic effects on metabolism, inflammation, and cell growth. Understanding this pathway is critical because its dysregulation is linked to cardiovascular disease, metabolic disorders, and cancer. Researchers study GO:0033211 to identify how adiponectin receptor activation translates into context-specific outcomes, including AMPK activation, ERK1/2 and p38 signaling, and PPARgamma-mediated transcriptional changes. The pathway is conserved across species and has been modeled in chicken myoblasts, human mesangial cells, and murine cardiac tissue.
adiponectin-activated signaling pathway At A Glance
| GO ID | GO:0033211 |
|---|---|
| GO term | adiponectin-activated signaling pathway |
| Ontology | biological_process |
| Synonym | adipocytokine signaling pathway; adiponectin-mediated signaling pathway; adiponectin-mediated signalling pathway |
| Major function | Transduces adiponectin receptor binding into downstream cellular regulation, including transcription |
| Key mediators | AMPK, ERK1/2, p38, PPARgamma |
| Cellular context | Surface receptor-initiated signaling in metabolic, vascular, and cancer cells |
| Physiological roles | Regulation of glucose and lipid metabolism, cell growth, differentiation, and calcification |
What Is GO:0033211?
GO:0033211 is the biological process in which adiponectin binds to its receptor on the cell surface and initiates a series of molecular signals that ultimately regulate a downstream cellular process, such as transcription. This includes receptor-proximal events, kinase cascades, and transcriptional responses, and is synonymous with adipocytokine signaling pathway and adiponectin-mediated signaling pathway.
Why Is adiponectin-activated signaling pathway Important in Cell Biology?
GO:0033211 is important because adiponectin signaling is a central node connecting adipose tissue to systemic metabolism, cardiovascular health, and cancer biology. Its activation can suppress hypertrophic signals in the heart, attenuate malignant mesothelioma growth, and trigger breast cancer cell death through metabolic reprogramming. Conversely, loss of adiponectin signaling promotes arterial calcification and dysregulated lipid handling. These findings make the pathway a high-value target for mechanistic studies and therapeutic hypothesis testing.
• Regulates glucose and lipid metabolism via AMPK and PPARgamma.
• Suppresses hypertrophic signaling in the heart.
• Inhibits arterial calcification in adiponectin-deficient mice.
• Attenuates angiotensin II-induced TGFbeta1 production in mesangial cells.
• Induces breast cancer cell death via fatty acid metabolic reprogramming.
• Reduces malignant mesothelioma cell growth.
• Controls chicken skeletal muscle satellite cell proliferation and differentiation through ERK1/2 and p38.
• Reduces lipid content in chicken myoblasts via AMPK activation.
• Provides a model for studying adipokine-receptor signal transduction.
• Offers CRISPR-tractable targets for metabolic and cancer research.
What Happens During adiponectin-activated signaling pathway?
Adiponectin binding and receptor activation
In simple terms: Adiponectin docks onto its receptor on the cell surface, starting the signal.
The pathway begins when adiponectin binds to its receptor on the surface of a target cell, initiating a series of molecular signals. This receptor engagement is the defining event of GO:0033211 and is required for all downstream effects, including metabolic and transcriptional regulation.
AMPK-dependent signaling
In simple terms: The signal often switches on AMPK, a cellular energy sensor.
Adiponectin signaling frequently activates AMPK to modulate lipid and glucose metabolism. In chicken myoblasts, adiponectin reduces lipid content by activating AMPK signaling. In human mesangial cells, adiponectin attenuates angiotensin II-induced TGFbeta1 production via an AMPK-dependent pathway. These studies show that AMPK is a recurrent mediator of GO:0033211.
ERK1/2 and p38 MAPK signaling
In simple terms: Other kinase cascades, ERK1/2 and p38, help control cell growth and differentiation.
Adiponectin regulates proliferation and differentiation of chicken skeletal muscle satellite cells via ERK1/2 and p38 signaling pathways. This demonstrates that GO:0033211 can branch into MAPK cascades to control cell fate decisions in muscle biology.
PPARgamma and transcriptional regulation
In simple terms: The signal can change which genes are turned on or off through PPARgamma.
Adiponectin and PPARgamma cooperate to regulate glucose and lipid metabolism, linking receptor signaling to transcriptional programs. This aligns with the GO definition, which explicitly includes regulation of a downstream cellular process such as transcription.
Metabolic reprogramming and cell death
In simple terms: In some cells, the signal rewires fat metabolism and can cause cell death.
Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming. This illustrates that GO:0033211 can produce context-dependent outcomes, including metabolic shifts that lead to apoptosis in cancer cells.
Cardiovascular and anti-calcification effects
In simple terms: In the heart and vessels, the signal dampens harmful growth and calcification.
Adiponectin-mediated modulation of hypertrophic signals in the heart shows that GO:0033211 can suppress pathological cardiac growth. In adiponectin-deficient mice, arterial calcification develops, indicating that adiponectin signaling regulates vascular calcification.
Key Genes Involved in GO:0033211 adiponectin-activated signaling pathway
The following genes and proteins are central to adiponectin-activated signaling pathway research, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADIPOQ | Encodes adiponectin, the ligand that initiates the pathway | Deficiency models show arterial calcification and metabolic dysregulation |
| ADIPOR1 | Adiponectin receptor 1, mediates ligand binding and signal initiation | Receptor-proximal events in GO:0033211 |
| ADIPOR2 | Adiponectin receptor 2, alternative receptor for adiponectin | Tissue-specific signaling outcomes |
| PRKAA1 | Catalytic subunit of AMPK, energy sensor kinase | Mediates lipid reduction and TGFbeta1 attenuation |
| PRKAA2 | Catalytic subunit of AMPK, energy sensor kinase | AMPK-dependent metabolic effects |
| MAPK1 | ERK2, MAPK pathway kinase | Controls satellite cell proliferation and differentiation |
| MAPK3 | ERK1, MAPK pathway kinase | Controls satellite cell proliferation and differentiation |
| MAPK14 | p38 MAPK, stress-activated kinase | Regulates myoblast differentiation |
| PPARG | PPARgamma, nuclear receptor transcription factor | Regulates glucose and lipid metabolism genes |
| TGFB1 | Transforming growth factor beta 1, profibrotic cytokine | Attenuated by adiponectin in mesangial cells |
| AGT | Angiotensinogen, precursor of angiotensin II | Adiponectin counteracts Ang II effects |
| FASN | Fatty acid synthase, lipogenic enzyme | Linked to fatty acid metabolic reprogramming in breast cancer |
| CPT1A | Carnitine palmitoyltransferase 1A, fatty acid oxidation | Potential mediator of adiponectin-induced metabolic shifts |
| ACACA | Acetyl-CoA carboxylase alpha, lipogenesis | AMPK substrate in lipid metabolism |
| MYOD1 | Myogenic differentiation factor | Satellite cell differentiation readout |
| MYF5 | Myogenic factor 5 | Satellite cell proliferation readout |
| PCNA | Proliferating cell nuclear antigen | Proliferation marker in mesothelioma and muscle cells |
| BCL2 | Anti-apoptotic protein | Modulated during adiponectin-induced cell death |
How Is adiponectin-activated signaling pathway Regulated?
Adiponectin-activated signaling is regulated at multiple levels. Receptor availability and adiponectin binding initiate the cascade, while AMPK acts as a central energy-sensing node that can be activated or modulated by metabolic status. PPARgamma provides transcriptional feedback that influences glucose and lipid metabolism genes. In muscle satellite cells, ERK1/2 and p38 signaling pathways regulate proliferation and differentiation, indicating that MAPK cross-talk shapes pathway output. In the heart, adiponectin-mediated modulation of hypertrophic signals suggests that the pathway is tuned to suppress pathological growth. In adiponectin-deficient mice, loss of ligand leads to arterial calcification, demonstrating that physiological regulation depends on intact adiponectin signaling.
adiponectin-activated signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADIPOQ | Arterial calcification | Adiponectin-deficient mouse |
| ADIPOR1 | Breast cancer cell death | Breast cancer cell lines with adiponectin treatment |
| ADIPOR2 | Malignant mesothelioma growth | Mesothelioma cell lines |
| PRKAA1 | Renal fibrosis / TGFbeta1 production | Human mesangial cells |
| PPARG | Glucose and lipid metabolism disorders | Metabolic cell models |
Cancer
Adiponectin signaling can suppress tumor growth in some contexts. Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming, linking GO:0033211 to metabolic vulnerability in breast cancer. Adiponectin pathway activation also attenuates malignant mesothelioma cell growth. These findings suggest that the pathway can be tumor-suppressive, depending on cell type and metabolic context.
Cardiovascular disease
Adiponectin-mediated modulation of hypertrophic signals in the heart indicates that GO:0033211 protects against pathological cardiac hypertrophy. In adiponectin-deficient mice, arterial calcification develops, showing that loss of this pathway promotes vascular calcification. These studies link the pathway to cardiovascular homeostasis and disease prevention.
Metabolic and renal disorders
Adiponectin reduces lipid content in chicken myoblasts by activating AMPK signaling, highlighting its role in lipid metabolism. In human mesangial cells, adiponectin attenuates angiotensin II-induced TGFbeta1 production via an AMPK-dependent pathway, suggesting a protective role in renal fibrosis. PPARgamma and adiponectin together regulate glucose and lipid metabolism, connecting the pathway to metabolic syndrome.
From adiponectin-activated signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of adiponectin signaling cause arterial calcification? | ADIPOQ knockout mouse |
| Does adiponectin receptor activation trigger cancer cell death? | ADIPOR1/ADIPOR2 knockout breast cancer cells |
| Is AMPK required for adiponectin-mediated lipid reduction? | PRKAA1/PRKAA2 knockout myoblasts |
| Does ERK1/2 or p38 mediate satellite cell differentiation? | MAPK1/MAPK3/MAPK14 knockout satellite cells |
| Does PPARgamma mediate transcriptional effects of adiponectin? | PPARG knockout metabolic cells |
| Does adiponectin attenuate TGFbeta1 production? | TGFB1 reporter mesangial cells with adiponectin treatment |
How to Study the adiponectin-activated signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Identify PPARgamma target genes |
| Phosphoproteomics | Kinase activation states | Map AMPK, ERK1/2, p38 signaling |
| Lipidomics | Lipid content and composition | Assess fatty acid reprogramming |
| Apoptosis assay | Cell death | Measure adiponectin-induced breast cancer cell death |
| Proliferation assay | Cell growth | Measure mesothelioma growth attenuation |
| Western blot | Protein expression and phosphorylation | Validate AMPK and MAPK activation |
| Immunofluorescence | Protein localization | Visualize receptor and downstream signaling |
Transcriptomic profiling
RNA-seq can identify transcriptional changes downstream of adiponectin receptor activation, as the GO definition includes regulation of transcription. Comparing wild-type and knockout cells reveals PPARgamma-dependent and independent gene programs.
Phosphoproteomics and kinase assays
Because AMPK, ERK1/2, and p38 are central mediators, phosphoproteomics and targeted kinase assays can quantify pathway activation states. These methods help map the signaling branches of GO:0033211.
Metabolic flux analysis
Adiponectin triggers fatty acid metabolic reprogramming in breast cancer cells, so metabolic flux assays and lipidomics are appropriate to measure pathway output. In myoblasts, lipid content measurements can assess AMPK-dependent effects.
Cell death and proliferation assays
Apoptosis and proliferation assays are used to measure outcomes such as breast cancer cell death and mesothelioma growth attenuation. These readouts connect pathway activity to cellular phenotypes.
How CRISPR Can Be Used to Study GO:0033211 adiponectin-activated signaling pathway
Knockout
CRISPR knockout of ADIPOR1, ADIPOR2, PRKAA1, PRKAA2, MAPK1, MAPK3, MAPK14, or PPARG can determine which components are required for adiponectin-activated signaling. For example, knocking out AMPK subunits tests whether lipid reduction depends on AMPK.
Point Mutation
Point mutations can dissect catalytic residues or phosphorylation sites in AMPK, ERK1/2, or p38 to test their role in pathway output. This approach helps distinguish kinase activity from scaffolding functions.
Knock-in
Knock-in of tagged adiponectin receptors or signaling kinases enables localization and interaction studies in live cells. Tagged knock-in models can also report pathway activation dynamics.
Overexpression
Overexpression of adiponectin, its receptors, or downstream effectors can amplify pathway output and test sufficiency in cancer and metabolic models. This is useful when ligand availability is limiting.
How EDITGENE Supports adiponectin-activated signaling pathway Research
Researchers studying adiponectin-activated signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway output, rather than merely correlated with it. CRISPR-based models provide the necessary gain- and loss-of-function tools to establish causality in metabolic, cardiovascular, and cancer contexts.
Contact EDITGENE today to design your custom CRISPR model for adiponectin-activated signaling pathway research.
Frequently Asked Questions About adiponectin-activated signaling pathway
What is the adiponectin-activated signaling pathway?
It is the biological process (GO:0033211) initiated by adiponectin binding to its receptor, leading to downstream cellular regulation such as transcription.
What genes are involved in adiponectin-activated signaling pathway?
Key genes include ADIPOQ, ADIPOR1, ADIPOR2, PRKAA1, PRKAA2, MAPK1, MAPK3, MAPK14, and PPARG.
What is GO:0033211?
GO:0033211 is the Gene Ontology identifier for adiponectin-activated signaling pathway, a biological process.
How does adiponectin signal through AMPK?
Adiponectin activates AMPK to reduce lipid content in myoblasts and to attenuate TGFbeta1 production in mesangial cells.
Does adiponectin signaling affect cancer?
Yes, adiponectin can trigger breast cancer cell death via fatty acid metabolic reprogramming and attenuate malignant mesothelioma growth.
What role does PPARgamma play in adiponectin signaling?
PPARgamma and adiponectin cooperate to regulate glucose and lipid metabolism, linking the pathway to transcription.
Can CRISPR be used to study adiponectin signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect pathway components and causality.
What diseases are linked to adiponectin-activated signaling?
Cardiovascular disease, arterial calcification, metabolic disorders, renal fibrosis, and certain cancers have been linked.
How is adiponectin signaling regulated?
It is regulated by receptor availability, AMPK activation, PPARgamma transcriptional feedback, and MAPK cross-talk.
What model systems are used to study adiponectin signaling?
Common models include adiponectin-deficient mice, chicken myoblasts and satellite cells, human mesangial cells, and cancer cell lines.
Conclusion
GO:0033211, the adiponectin-activated signaling pathway, is a biologically_process that integrates adipokine receptor binding with AMPK, MAPK, and PPARgamma signaling to control metabolism, cell growth, and transcription. Its dysregulation is implicated in cancer, cardiovascular calcification, and metabolic disease, making it a compelling area for mechanistic research. CRISPR-based knockout, point mutation, knock-in, and overexpression models, combined with transcriptomics and phosphoproteomics, provide robust tools to dissect this pathway and identify therapeutic targets.
References
- 1. Pham DV et al.. 2022. Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming.. J Exp Clin Cancer Res 41(1):9 PMID: 34986886
- 2. Hu Q et al.. 2022. Adiponectin Reduces Lipid Content in Chicken Myoblasts by Activating AMPK Signaling Pathway.. Biosci Rep 42(6) PMID: 35603780
- 3. Niu K et al.. 2012. Adiponectin pathway attenuates malignant mesothelioma cell growth.. Am J Respir Cell Mol Biol 46(4):515-23 PMID: 22095628
- 4. Guo L et al.. 2025. Adiponectin regulates proliferation and differentiation of chicken skeletal muscle satellite cells via ERK1/2 and p38 signaling pathways.. Poult Sci 104(2):104813 PMID: 39823838
- 5. Tan M et al.. 2015. Adiponectin attenuates Ang Ⅱ-induced TGFβ1 production in human mesangial cells via an AMPK-dependent pathway.. Biotechnol Appl Biochem 62(6):848-54 PMID: 25471552
- 6. Luo XH et al.. 2009. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification.. J Bone Miner Res 24(8):1461-8 PMID: 19257834
- 7. Shibata R et al.. 2004. Adiponectin-mediated modulation of hypertrophic signals in the heart.. Nat Med 10(12):1384-9 PMID: 15558058
- 8. Kamon J et al.. 2003. [The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism].. Nihon Yakurigaku Zasshi 122(4):294-300 PMID: 14501164
